| |
| |
|
| Insider
Information: |
Mercier Johanna |
| Relationship: |
Chief Commercial Officer |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
118,432 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,721,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
118,432 |
|
|
| Total
Value |
$7,721,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Commercial Officer |
2024-03-10 |
118,432 |
2020-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2024-03-10 |
4 |
D |
$75.12 |
$342,472 |
D/D |
(4,559) |
118,432 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,844 |
122,991 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2024-01-31 |
4 |
D |
$78.26 |
$1,761,554 |
D/D |
(22,509) |
113,147 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
74,055 |
135,656 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2024-01-09 |
4 |
AS |
$85.23 |
$702,466 |
D/D |
(8,242) |
82,729 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,730 |
92,218 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-12-10 |
4 |
D |
$79.02 |
$98,538 |
D/D |
(1,247) |
90,971 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-09-10 |
4 |
D |
$76.00 |
$95,456 |
D/D |
(1,256) |
89,488 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,730 |
90,744 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,505 |
51,500 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-07-24 |
4 |
D |
$77.66 |
$246,493 |
D/D |
(3,174) |
48,326 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-06-10 |
4 |
D |
$78.12 |
$99,369 |
D/D |
(1,272) |
43,995 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,730 |
45,267 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-03-10 |
4 |
D |
$79.50 |
$406,722 |
D/D |
(5,116) |
82,225 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,976 |
87,341 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-01-24 |
4 |
D |
$84.02 |
$1,287,607 |
D/D |
(15,325) |
76,365 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2023-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
67,394 |
91,690 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-12-10 |
4 |
D |
$87.97 |
$40,730 |
D/D |
(463) |
40,430 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
990 |
40,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-09-10 |
4 |
D |
$65.28 |
$29,898 |
D/D |
(458) |
39,903 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
990 |
40,361 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-07-24 |
4 |
D |
$60.80 |
$194,925 |
D/D |
(3,206) |
39,371 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,505 |
42,577 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
990 |
35,534 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Commercial Officer |
• • – |
2022-06-10 |
4 |
D |
$60.74 |
$28,062 |
D/D |
(462) |
35,072 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
